11251005

Source:http://linkedlifedata.com/resource/pubmed/id/11251005

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists.
Subject	Predicate	Object	Context
pubmed-article:11251005	rdf:type	pubmed:Citation	lld:pubmed
pubmed-article:11251005	lifeskim:mentions	umls-concept:C0030705	lld:lifeskim
pubmed-article:11251005	lifeskim:mentions	umls-concept:C0684249	lld:lifeskim
pubmed-article:11251005	lifeskim:mentions	umls-concept:C0442027	lld:lifeskim
pubmed-article:11251005	lifeskim:mentions	umls-concept:C0146224	lld:lifeskim
pubmed-article:11251005	lifeskim:mentions	umls-concept:C0348016	lld:lifeskim
pubmed-article:11251005	lifeskim:mentions	umls-concept:C0205390	lld:lifeskim
pubmed-article:11251005	lifeskim:mentions	umls-concept:C2603343	lld:lifeskim
pubmed-article:11251005	lifeskim:mentions	umls-concept:C1707454	lld:lifeskim
pubmed-article:11251005	pubmed:issue	6	lld:pubmed
pubmed-article:11251005	pubmed:dateCreated	2001-3-19	lld:pubmed
pubmed-article:11251005	pubmed:abstractText	Topotecan, administered intravenously, is active in small-cell lung cancer (SCLC). In this study, the comparability of oral topotecan to IV topotecan was investigated.	lld:pubmed
pubmed-article:11251005	pubmed:language	eng	lld:pubmed
pubmed-article:11251005	pubmed:journal	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:11251005	pubmed:citationSubset	IM	lld:pubmed
pubmed-article:11251005	pubmed:chemical	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:11251005	pubmed:chemical	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:11251005	pubmed:status	MEDLINE	lld:pubmed
pubmed-article:11251005	pubmed:month	Mar	lld:pubmed
pubmed-article:11251005	pubmed:issn	0732-183X	lld:pubmed
pubmed-article:11251005	pubmed:author	pubmed-author:RossGG	lld:pubmed
pubmed-article:11251005	pubmed:author	pubmed-author:RichardsonGG	lld:pubmed
pubmed-article:11251005	pubmed:author	pubmed-author:MoreauLL	lld:pubmed
pubmed-article:11251005	pubmed:author	pubmed-author:PujolJ LJL	lld:pubmed
pubmed-article:11251005	pubmed:author	pubmed-author:LaneSS	lld:pubmed
pubmed-article:11251005	pubmed:author	pubmed-author:GatzemeierUU	lld:pubmed
pubmed-article:11251005	pubmed:author	pubmed-author:RansonMM	lld:pubmed
pubmed-article:11251005	pubmed:author	pubmed-author:RivièreAA	lld:pubmed
pubmed-article:11251005	pubmed:author	pubmed-author:von PawelJJ	lld:pubmed
pubmed-article:11251005	pubmed:author	pubmed-author:SteppertCC	lld:pubmed
pubmed-article:11251005	pubmed:author	pubmed-author:BildatSS	lld:pubmed
pubmed-article:11251005	pubmed:author	pubmed-author:CamlettII	lld:pubmed
pubmed-article:11251005	pubmed:issnType	Print	lld:pubmed
pubmed-article:11251005	pubmed:day	15	lld:pubmed
pubmed-article:11251005	pubmed:volume	19	lld:pubmed
pubmed-article:11251005	pubmed:owner	NLM	lld:pubmed
pubmed-article:11251005	pubmed:authorsComplete	Y	lld:pubmed
pubmed-article:11251005	pubmed:pagination	1743-9	lld:pubmed
pubmed-article:11251005	pubmed:dateRevised	2006-11-15	lld:pubmed
pubmed-article:11251005	pubmed:meshHeading	pubmed-meshheading:11251005...	lld:pubmed
pubmed-article:11251005	pubmed:meshHeading	pubmed-meshheading:11251005...	lld:pubmed
pubmed-article:11251005	pubmed:meshHeading	pubmed-meshheading:11251005...	lld:pubmed
pubmed-article:11251005	pubmed:meshHeading	pubmed-meshheading:11251005...	lld:pubmed
pubmed-article:11251005	pubmed:meshHeading	pubmed-meshheading:11251005...	lld:pubmed
pubmed-article:11251005	pubmed:meshHeading	pubmed-meshheading:11251005...	lld:pubmed
pubmed-article:11251005	pubmed:meshHeading	pubmed-meshheading:11251005...	lld:pubmed
pubmed-article:11251005	pubmed:meshHeading	pubmed-meshheading:11251005...	lld:pubmed
pubmed-article:11251005	pubmed:meshHeading	pubmed-meshheading:11251005...	lld:pubmed
pubmed-article:11251005	pubmed:meshHeading	pubmed-meshheading:11251005...	lld:pubmed
pubmed-article:11251005	pubmed:meshHeading	pubmed-meshheading:11251005...	lld:pubmed
pubmed-article:11251005	pubmed:meshHeading	pubmed-meshheading:11251005...	lld:pubmed
pubmed-article:11251005	pubmed:meshHeading	pubmed-meshheading:11251005...	lld:pubmed
pubmed-article:11251005	pubmed:year	2001	lld:pubmed
pubmed-article:11251005	pubmed:articleTitle	Phase ii comparator study of oral versus intravenous topotecan in patients with chemosensitive small-cell lung cancer.	lld:pubmed
pubmed-article:11251005	pubmed:affiliation	Asklepios Fachklinik, Gauting bei München, Munich, Germany.	lld:pubmed
pubmed-article:11251005	pubmed:publicationType	Journal Article	lld:pubmed
pubmed-article:11251005	pubmed:publicationType	Clinical Trial	lld:pubmed
pubmed-article:11251005	pubmed:publicationType	Randomized Controlled Trial	lld:pubmed
pubmed-article:11251005	pubmed:publicationType	Research Support, Non-U.S. Gov't	lld:pubmed
pubmed-article:11251005	pubmed:publicationType	Clinical Trial, Phase II	lld:pubmed
http://linkedlifedata.com/r...	pubmed:referesTo	pubmed-article:11251005	lld:pubmed
http://linkedlifedata.com/r...	pubmed:referesTo	pubmed-article:11251005	lld:pubmed
http://linkedlifedata.com/r...	pubmed:referesTo	pubmed-article:11251005	lld:pubmed
http://linkedlifedata.com/r...	pubmed:referesTo	pubmed-article:11251005	lld:pubmed
http://linkedlifedata.com/r...	pubmed:referesTo	pubmed-article:11251005	lld:pubmed